Metformin Current Events | Metformin News
|
|
|
Sort By:
Page Views | Date |
Diabetes medication and lifestyle changes can help treat weight gain induced by antipsychotic drugs
Lifestyle intervention and the drug metformin are both effective against antipsychotic-induced weight gain, and treatment is most effective when the two therapies are combined, according to a study in the January 9/16 issue of JAMA. view more (2008-01-09)
Pancreatic cancer risk decreased by one anti-diabetic therapy, increased by others
The antidiabetic medication metformin is associated with a reduced risk of pancreatic cancer in diabetics, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. view more (2009-08-03)
Standard therapy more effective than diabetes drug in helping women with PCOS achieve pregnancy
Metformin, a drug used to treat diabetes and once thought to have great promise in overcoming the infertility associated with polycystic ovary syndrome (PCOS), is less effective than the standard fertility drug treatment, clomiphene. view more (2007-02-08)
What is the relationship between hepatocellular carcinoma and type 2 diabetes mellitus?
Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide and the third leading cause of cancer-related deaths. view more (2009-06-12)
Drug could improve pregnancy outcomes in wider range of women with insulin resistance
Women who are obese, have type 2 diabetes or a family history of type 2 diabetes could one day have more successful pregnancies because of a study at Washington University School of Medicine in St. Louis. view more (2007-09-07)
Metformin increases pathologic complete response rates in breast cancer patients with diabetes
Metformin, the common first-line drug for type 2 diabetes, may be effective in increasing pathologic complete response rates in diabetic women with early stage breast cancer who took the drug during chemotherapy prior to having surgery, paving the way for further research of the drug as a potential cancer therapy, according to researchers at The... view more... (2008-06-03)
Old diabetes drug teaches experts new tricks
Research from the Johns Hopkins Children's Center reveals that the drug most commonly used in type 2 diabetics who don't need insulin works on a much more basic level than once thought, treating persistently elevated blood sugar - the hallmark of type 2 diabetes - by regulating the genes that control its production. view more (2009-05-15)
Standard treatment more effective than diabetes drug for achieving pregnancy in fertility disorder
Metformin, a drug used to treat diabetes and thought to hold great promise at overcoming the infertility associated with polycystic ovary syndrome (PCOS), is less useful for helping women with the condition achieve pregnancy than is the standard treatment with the infertility drug clomiphene, report researchers in an NIH research network. view more (2007-02-08)
M. D. Anderson study finds common diabetic therapy reduces risk of pancreatic cancer
Taking the most commonly-prescribed anti-diabetic drug, metformin, reduces an individual's risk of developing pancreatic cancer by 62 percent. view more (2009-08-03)
UT Southwestern physicians bust myths about insulin
People diagnosed with type 2 diabetes often resist taking insulin because they fear gaining weight, developing low blood sugar and seeing their quality of life decline. view more (2009-08-11)
Common diabetes drug may 'revolutionize' cancer therapies
Researchers at McGill University and the University of Pennsylvania have discovered that a widely used anti-diabetic drug can boost the immune system and increase the potency of vaccines and cancer treatments. view more (2009-06-04)
Popular diabetes treatment could trigger pancreatitis, pancreatic cancer
A drug widely used to treat Type 2 diabetes may have unintended effects on the pancreas that could lead to a form of low-grade pancreatitis in some patients and a greater risk of pancreatic cancer in long-term users, UCLA researchers have found. view more (2009-05-01)
Glitazones have not yet been sufficiently investigated
There is so far a lack of scientific evidence that glitazones are better than alternative therapies at reducing mortality or complications caused by blood vessel damage in people with type 2 diabetes. view more (2009-04-02)
Diabetes drug kills cancer stem cells in combination treatment in mice
In a one-two punch, a familiar diabetes drug reduced tumors faster and prolonged remission in mice longer than chemotherapy alone by targeting cancer stem cells, Harvard Medical School researchers reported in the September 14 online first edition of Cancer Research, a journal of the American Association for Cancer Research. view more (2009-09-14)
Traditional Chinese medicine for diabetes has scientific backing
Reports of a traditional Chinese medicine having beneficial effects for people suffering from type 2 diabetes now has some scientific evidence to back up the claims. view more (2006-08-01)
Benefit of glinides is not proven
The benefit of glinides in the treatment of type 2 diabetes is not scientifically proven. Nor do they perform better than other antidiabetics available in tablet form, such as metformin and sulfonylureas. view more (2009-06-18)
Weight loss improves bladder control in women with prediabetes
Losing a modest amount of weight through dietary changes and increased physical activity reduces the occurrence of urinary incontinence (UI) in women with prediabetes, a condition in which blood glucose levels are higher than normal but not yet diabetic. view more (2006-01-27)
New 4-year Study To Examine Effects Of Reducing Insulin Resistance On Cardiovascular Risk
Takeda UK Ltd (Takeda) today confirmed that 60 UK centres will participate in the PROspective pioglitAzone Clinical Trial In macroVascular Events (PROactive). PROactive will enroll 5,000 patients in 10 European countries and will last four years. Of the 5,000 patients who will be enrolled it is anticipated that 800 will be from the UK. The trial... view more... (2001-08-29)
Routine diabetes screenings could cut health-care costs
Screening adults for diabetes could result in significant cost-savings for health care systems compared to the costs of not screening individuals at all. view more (2009-06-08)
A decade later, lifestyle changes or metformin still lower type 2 diabetes risk
Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent compared with placebo in people at high risk for the disease, researchers conclude based on 10 years of data. view more (2009-10-29)
|
|
|
|
Sort By:
Page Views | Date |
|
